Dr. Brijesh Sukumaran: Assistant Professor at Sunandan Divatia School of Science, NMIMS (Deemed-to-be) University, Mumbai, India
Dr. Brijesh Sukumaran is an Assistant Professor at the Sunandan Divatia School of Science, NMIMS University, Mumbai, India, with over 15 years of experience in academia and research. He specializes in Microbiology, Immunology, Pharmacology, and Nano-drug delivery systems, particularly focused on the design and application of nanoparticles for drug delivery in chronic diseases like rheumatoid arthritis and psoriasis. With a Ph.D. in Applied Biology from The Foundation for Medical Research, Mumbai, Dr. Sukumaran is deeply involved in translational research and the development of therapeutic strategies leveraging both synthetic and natural compounds. He has published more than 30 research papers, contributed to several patents, and guided multiple Ph.D. and M.Sc. students.
Online Profiles
Education
Dr. Sukumaran completed his undergraduate degree in Microbiology (B.Sc.) from H.P.T. Arts & R.Y.K. Science College, Nasik, under the University of Pune in 1998. He continued his academic journey with a Master’s in Microbiology (M.Sc.) from the University of Pune in 2000. His doctoral research, completed in 2010 at The Foundation for Medical Research, Mumbai, focused on Applied Biology, exploring innovative approaches in drug delivery systems. This advanced education laid the foundation for his deep understanding of molecular biology, pharmacology, and nanotechnology.
Research Focus
Dr. Sukumaran’s research interests revolve around the design, formulation, and evaluation of advanced drug delivery systems, specifically targeting chronic inflammatory diseases such as rheumatoid arthritis and psoriasis. His work includes the use of solid lipid nanoparticles (SLNs), nanoemulsions, niosomes, and nanostructured lipid carriers (NLCs) for effective oral and topical drug delivery. A significant portion of his research also delves into exploring the therapeutic potential of plant-derived compounds in alleviating mental health conditions, such as anxiety and depression, by assessing their effects in both in vitro and animal models. His ultimate goal is to bridge the gap between laboratory research and clinical application through cutting-edge nanotechnology.
Experience
Dr. Sukumaran’s academic journey began at National Chemical Laboratory as a Project Assistant in 2000, where he first worked on biotechnological and pharmacological projects. After a brief transition to the pharmaceutical industry as an Area Sales Officer at Allergan India Ltd., he returned to research as a Research Assistant at The Foundation for Medical Research in 2009. There, he completed his postdoctoral work before transitioning into academia. Since June 2011, he has been an Assistant Professor at NMIMS University, where he has taught numerous undergraduate and postgraduate courses in Biomedical Science and Biological Sciences. He has also played a pivotal role in guiding Ph.D. and M.Sc. students, actively shaping the academic and research directions at the institution.
Research Timeline
-
2000–2001: Worked as a Project Assistant at the National Chemical Laboratory, Pune.
-
2009–2010: Completed a Post-doctoral Fellowship at The Foundation for Medical Research, Mumbai, focusing on advanced drug delivery systems.
-
2011–Present: Assistant Professor at NMIMS University, Mumbai, leading various research projects on nano-drug delivery, pharmacology, and natural product therapeutics.
-
2016–2023: Supervised and mentored multiple Ph.D. and M.Sc. students, several of whom have completed their theses on innovative drug delivery systems and pharmacological evaluations.
-
2025: Ongoing research on nanocarriers for topical drug delivery in arthritis and psoriasis, with two Ph.D. theses currently submitted and pending defense.
Awards & Honors
Dr. Sukumaran received the Best Faculty award for the academic year 2018-2019 from the Sunandan Divatia School of Science, NMIMS University. This recognition was given in honor of his exceptional academic leadership, commitment to research excellence, and consistent contributions to improving the educational experience for students. His dedication to his students and innovative research has made him a respected figure at NMIMS University.
Recent Publication
Dr. Sukumaran’s research has led to over 30 publications in prestigious journals. Some of his most recent work includes:
1. Development of a Co-Loaded Microemulsion Composite Hydrogel for Enhanced Dermal Delivery of Cyclosporine A and Quercetin for Psoriasis Treatment
-
Journal: BioNanoScience
-
Date: September 2025
-
Contributors: Ruchita Joshi, Brijesh Sukumaran
-
Summary: This article explores the development of a novel co-loaded microemulsion composite hydrogel aimed at enhancing the dermal delivery of Cyclosporine A (CsA) and Quercetin for psoriasis treatment. The hydrogel’s formulation is designed to offer improved stability and sustained release of the drugs, targeting the inflammatory pathways in psoriasis more effectively. The study demonstrates significant therapeutic potential in enhancing drug penetration into the skin while minimizing systemic toxicity.
2. Rethinking Arthritis: Exploring Its Types and Emerging Management Strategies
-
Journal: Inflammopharmacology
-
Date: July 1, 2025
-
Contributors: Namrata Britto, Rajasekhar Reddy Alavala, S. Brijesh
-
Summary: This comprehensive review delves into various forms of arthritis, with a particular focus on rheumatoid arthritis (RA) and psoriatic arthritis (PsA). It discusses the pathophysiology, challenges in treatment, and the latest advancements in both pharmacological and non-pharmacological management strategies. The paper also emphasizes emerging therapeutic targets, including biologics and personalized medicine, and provides insights into the evolving landscape of arthritis management.
3. Handbook of Coriander (Coriandrum Sativum)
-
Book Chapter: Handbook of Coriander (Coriandrum Sativum)
-
Year: 2022
-
Contributors: Mohamed Fawzy Ramadan
-
Summary: This book chapter discusses the pharmacological properties of coriander (Coriandrum sativum), focusing on its therapeutic potential in treating various diseases. Topics include coriander’s role as an anti-inflammatory, antimicrobial, and anti-cancer agent, alongside its ability to alleviate symptoms of metabolic disorders. The chapter explores both the biological activity of coriander’s active compounds and the potential mechanisms by which it exerts its effects.
4. Hyaluronic Acid-Coated Solid Lipid Nanoparticles Enhance Antirheumatic Activity and Reduce Toxicity of Methotrexate
-
Journal: Nanomedicine
-
Date: July 2022
-
Contributors: Yashika Mirchandani, Vandana B. Patravale, S. Brijesh
-
Summary: This research investigates the potential of hyaluronic acid-coated solid lipid nanoparticles (SLNs) to enhance the therapeutic efficacy and reduce the toxicity of methotrexate (MTX) in rheumatoid arthritis treatment. The study reports the successful formulation of MTX-loaded SLNs, which showed improved drug release and anti-rheumatic activity in animal models, while also significantly reducing systemic toxicity compared to free methotrexate.
5. Solid Lipid Nanoparticles for Hydrophilic Drugs
-
Journal: Journal of Controlled Release
-
Date: July 2021
-
Contributors: Yashika Mirchandani, Vandana B. Patravale, Brijesh S.
-
Summary: This article highlights the application of solid lipid nanoparticles (SLNs) for the delivery of hydrophilic drugs. It discusses various strategies to optimize the encapsulation efficiency, stability, and controlled release of hydrophilic bioactive molecules. The study provides insight into the potential of SLNs for enhancing the bioavailability of poorly soluble hydrophilic drugs, making them a promising solution for drug delivery systems.
Strength for the Best Innovator Award
1. Cutting-Edge Nanotechnology in Drug Delivery
Dr. Brijesh Sukumaran’s innovative research in the development and application of nano-drug delivery systems stands as a cornerstone of his work. His pioneering efforts in designing nanoparticles such as solid lipid nanoparticles (SLNs), nanoemulsions, and nanostructured lipid carriers (NLCs) for chronic diseases like rheumatoid arthritis and psoriasis have revolutionized the way therapeutics are delivered. These systems enhance drug bioavailability, improve targeting, and reduce toxicity, making him a leader in the field of nanomedicine.
2. Focus on Translational Research
Dr. Sukumaran’s commitment to bridging the gap between laboratory research and clinical application underscores his status as an innovator. His translational research approach is evident in his development of co-loaded microemulsion composite hydrogels for the targeted dermal delivery of Cyclosporine A and Quercetin. His work on integrating synthetic and natural compounds to treat chronic diseases like psoriasis not only advances scientific knowledge but also brings practical therapeutic solutions closer to patients.
3. Mentorship and Academic Leadership
With over 15 years of experience in academia, Dr. Sukumaran has been a trailblazer in educating and mentoring the next generation of researchers. His ability to guide Ph.D. and M.Sc. students, shape academic curriculum, and foster a collaborative research environment at NMIMS University is a testament to his leadership. Many of his students are contributing significantly to the field of drug delivery, creating a lasting impact on research and innovation.
4. Recognition and Awards for Excellence
Dr. Sukumaran’s dedication to research and education has been recognized by multiple honors, including the Best Faculty award from NMIMS University in 2018-2019. His ability to translate complex scientific concepts into impactful solutions for human health has earned him accolades from both his peers and students, reinforcing his reputation as a top innovator in biomedical sciences.
5. Multidisciplinary Research for Chronic Disease Management
Dr. Sukumaran’s multidisciplinary approach to addressing chronic diseases such as arthritis and psoriasis reflects his innovative mindset. His recent publication on emerging arthritis management strategies and the development of hyaluronic acid-coated solid lipid nanoparticles for enhanced methotrexate delivery highlights his contributions not just to pharmacology, but also to material science, immunology, and molecular biology. His innovative work in chronic disease management holds the potential to significantly alter therapeutic strategies and improve patient outcomes worldwide.